New Delhi, April 26: The Narcotics Control Bureau (NCB) has launched a sweeping digital crackdown called Operation WIPE — short for Web-based Illicit Activities Prevention and Enforcement — uncovering 122 instances of illegal online drug trafficking across 62 substances, including highly abused pharmaceuticals such as Clonazepam, Diazepam, and Fentanyl. The operation marks a decisive shift in India's anti-narcotics strategy, moving from reactive enforcement to proactive digital surveillance of e-commerce and B2B platforms.

What Is Operation WIPE and How It Works

Operation WIPE is designed to prevent the misuse of online platforms for the illegal sale and distribution of pharmaceutical drugs regulated under the Narcotic Drugs and Psychotropic Substances (NDPS) Act. The NCB's technical teams deployed advanced monitoring tools and leveraged international intelligence inputs to scan the surface web for suspicious drug listings.

Of the 122 violations identified, 58 substances fall under the NDPS Act, while four are classified as controlled substances. The NCB issued formal notices to implicated online platforms, directing immediate removal of flagged listings and suspension of suspicious vendors.

Platforms including IndiaMart, TradeIndia, and Dial4Trade have already taken corrective action following verification by NCB officials, including delisting of prohibited pharmaceutical products and banning of rogue sellers.

Key Findings and Substances Flagged

The operation targeted a range of commonly abused pharmaceutical drugs that are legally regulated but frequently exploited for illicit purposes. Fentanyl — a synthetic opioid up to 100 times more potent than morphine — was among the most alarming substances detected, given its role in overdose deaths globally.

A comprehensive list of NDPS-regulated substances has been shared with online platforms to enable proactive identification and removal of such listings before they facilitate actual trafficking. The NCB emphasized that no legitimate documentation was being sought by vendors, raising serious public health and law enforcement concerns.

Connection to Operation MED-MAX: A Transnational Syndicate Exposed

Operation WIPE builds directly on the success of Operation MED-MAX, an earlier crackdown conducted in July 2025, which dismantled a highly sophisticated transnational drug trafficking syndicate operating across Asia, North America, Europe, and Australia.

That operation was conducted jointly by NCB India, the US Drug Enforcement Administration (DEA), the Australian Federal Police (AFP), and other foreign drug law enforcement agencies. The case originated from the seizure of 3.7 kg of tramadol tablets in India, which unravelled an organised global network exploiting digital B2B platforms for illicit pharmaceutical trade.

Investigations revealed that the syndicate operated a call centre in Udupi, Karnataka, which processed global orders through a leading online B2B platform. Payments were routed through cryptocurrencies, PayPal, and international remittance channels, while overseas re-shippers handled last-mile delivery to customers worldwide.

The coordinated global crackdown led to multiple arrests, identification of the kingpin based in the UAE, and enforcement actions abroad, including seizures and dismantling of clandestine facilities.

Why This Matters: India's Digital Drug Economy Under Scrutiny

The emergence of online drug trafficking through mainstream B2B and e-commerce platforms represents a new frontier in narcotics enforcement that traditional policing methods are ill-equipped to handle. The fact that platforms like IndiaMart — used daily by millions of legitimate businesses — were being exploited for drug sales underscores a systemic vulnerability in India's digital commerce ecosystem.

Critics and public health experts argue that platform accountability must be strengthened through clearer regulatory mandates, faster takedown protocols, and mandatory reporting of suspicious pharmaceutical listings. The NCB's move to share a pre-approved list of NDPS substances with platforms is a step in the right direction, but enforcement gaps remain significant.

This also comes amid rising global concern over the fentanyl crisis, which has devastated communities in the United States and is increasingly being tracked in South and Southeast Asia. India's role as a pharmaceutical manufacturing hub makes it both a target and a potential transit point for synthetic opioid trafficking networks.

What Happens Next

The NCB has confirmed that its technical teams will continue monitoring the surface web using advanced tools and real-time international intelligence to detect emerging threats. Further notices to non-compliant platforms are expected, and legal action against vendors identified during the operation is likely to follow.

As India's digital economy grows, the intersection of e-commerce and narcotics trafficking will demand stronger inter-agency coordination, platform regulation, and cross-border intelligence sharing. Operation WIPE signals that the NCB is now treating the digital domain as a primary battleground in India's war on drugs — a posture that is likely to intensify in the months ahead.